These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 21872377

  • 1. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J.
    Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
    [Abstract] [Full Text] [Related]

  • 2. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 3. Primary IgA nephropathy: new insights into pathogenesis.
    Barratt J, Feehally J.
    Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
    [Abstract] [Full Text] [Related]

  • 4. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A.
    Nefrologia; 2010 Jul; 30(5):501-7. PubMed ID: 20882091
    [Abstract] [Full Text] [Related]

  • 5. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Jul; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 7. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
    Monteiro RC, Leroy V, Launay P, Moura IC, Arcos-Fajardo M, Benhamou M, Haddad E.
    Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
    [Abstract] [Full Text] [Related]

  • 8. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 9. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 10. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis of IgA nephropathy.
    Lai KN.
    Nat Rev Nephrol; 2012 Mar 20; 8(5):275-83. PubMed ID: 22430056
    [Abstract] [Full Text] [Related]

  • 12. The pathogenetic aspects and gene polymorphisms of IgA nephropathy.
    Maixnerová D, Merta M, Reiterová J, Stekrová J, Rysavá R, Obeidová H, Tesar V.
    Prague Med Rep; 2006 Mar 20; 107(2):171-88. PubMed ID: 17066738
    [Abstract] [Full Text] [Related]

  • 13. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 20; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 14. Predictors of prognosis in IgA nephropathy.
    Tomino Y.
    Kaohsiung J Med Sci; 2012 Oct 20; 28(10):517-20. PubMed ID: 23089315
    [Abstract] [Full Text] [Related]

  • 15. Molecular Insights into the Pathogenesis of IgA Nephropathy.
    Robert T, Berthelot L, Cambier A, Rondeau E, Monteiro RC.
    Trends Mol Med; 2015 Dec 20; 21(12):762-775. PubMed ID: 26614735
    [Abstract] [Full Text] [Related]

  • 16. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation].
    Matousovic K, Konecný K, Mĕstecký J, Tomana M, Novák J.
    Cas Lek Cesk; 2002 Nov 22; 141(23):729-34. PubMed ID: 12650029
    [Abstract] [Full Text] [Related]

  • 17. [Mesangial proliferative glomerulonephritis].
    Yamada A.
    Nihon Rinsho; 2004 Oct 22; 62(10):1842-6. PubMed ID: 15500128
    [Abstract] [Full Text] [Related]

  • 18. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN, Ovary Z, Lamm ME.
    Lab Invest; 1987 Sep 22; 57(3):269-76. PubMed ID: 3306149
    [Abstract] [Full Text] [Related]

  • 19. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S.
    Am J Kidney Dis; 2001 Nov 22; 38(5):1082-8. PubMed ID: 11684563
    [Abstract] [Full Text] [Related]

  • 20. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.